轉投資公司 | 持股股數 | 持股比例 |
Center Biotherapeutics Inc |
2,228,283 |
100.00% |
永昕生物醫藥股份有限公司 |
41,974,314 |
20.00% |
玉晟管理顧問股份有限公司 |
98,437,500 |
100.00% |
東曜藥業股份有限公司 |
213,311,700 |
28.00% |
Centerlab Investment Holding Limited(HK) |
39,347,384 |
100.00% |
Center Laboratories Limited(HK) |
39,871,908 |
100.00% |
益安生醫股份有限公司 |
27,411,028 |
30.00% |
順天醫藥生技股份有限公司 |
57,776,874 |
34.00% |
Fangyuan Growth SPC PCJ Healthcare Fund SP |
- |
33.00% |
PCJ Capital Management Limited |
- |
25.00% |
山水生技創投有限合夥 |
- |
50.00% |
博晟生醫股份有限公司 |
37,580,008 |
30.00% |
奧孟亞股份有限公司 |
8,276,369 |
17.00% |
Center Venture Holding I Limited |
1 |
100.00% |
Center Venture Holding II Limited |
13,929,351 |
100.00% |
Center Venture Holding III Limited |
1 |
100.00% |
顥晟生醫股份有限公司 |
5,000,000 |
40.00% |
建誼生技股份有限公司 |
10,075,000 |
19.00% |
Bioflag International Corporation |
38,259,249 |
57.00% |